Skip to content
  • Sunday, 26 July 2026
  • 3:13 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Remepy’s Hybridopa, a Pioneer in AI-Driven Hybrid Drugs, Demonstrates Significant Efficacy in Parkinson’s Phase IIa Trial
Laboratory Automation & Robotics

Remepy’s Hybridopa, a Pioneer in AI-Driven Hybrid Drugs, Demonstrates Significant Efficacy in Parkinson’s Phase IIa Trial

Lana Keisha Jul 17, 2026 0

San Francisco, CA – May 2026 – Remepy, a burgeoning health technology startup at the vanguard of integrating pharmaceutical and…

Read More
Environmental & Analytical Chemistry

The Genetic Ancestry of Beefalo Under Scrutiny: Landmark Study Reveals Little to No Bison DNA in Iconic Hybrid Breed

Abdurrohim Arsyad Jul 8, 2026 0

A groundbreaking genome analysis of Beefalo, a hybrid livestock breed celebrated for its supposed fusion of cattle and bison genetics,…

Read More
Advanced Materials Science

UC San Diego Researchers Unveil High-Efficiency Piezoelectric Hybrid Power Converters to Address Escalating Energy Demands in Modern Data Centers

Nila Kartika Wati May 3, 2026 0

The global digital infrastructure is currently facing an unprecedented energy crisis, driven largely by the rapid expansion of artificial intelligence,…

Read More
Pharmaceutical R&D

Merck KGaA and Remepy Forge Groundbreaking Partnership to Pioneer "Hybrid Drugs" for Rare Cancers

Teuku Ryan Apr 28, 2026 0

In a move that signals a significant shift in pharmaceutical innovation, Merck KGaA has announced a strategic collaboration with Remepy,…

Read More
Advanced Materials Science

UC San Diego Researchers Unveil Hybrid Piezoelectric Chip Design to Enhance Data Center Power Efficiency and GPU Performance

Nila Kartika Wati Apr 18, 2026 0

The global surge in artificial intelligence, cloud computing, and large-scale data processing has placed an unprecedented strain on the world’s…

Read More
Advanced Materials Science

University of California San Diego Engineers Develop High Efficiency Hybrid Power Converter to Optimize GPU Energy Consumption in Data Centers

Nila Kartika Wati Apr 11, 2026 0

As the global digital infrastructure expands at an unprecedented rate, driven largely by the rapid proliferation of artificial intelligence and…

Read More
Gene Therapy Breakthrough Offers Non-Addictive Path for Chronic Pain Treatment via Brain-Specific Circuit TargetingMolecular Switch FLI-1 Found Essential for Blood Stem Cell Activation and RegenerationTWiV 1285: Encapsidating Viruses 2025Galahadodon rhysi: A Swift, Terrestrial Crocodylomorph Relative Unearthed in Triassic Britain
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ